Evidence map›Paper›PMID 23914737›Full record

ArticleBMC immunology2013

Quantification of total T-cell receptor diversity by flow cytometry and spectratyping.

Stanca M Ciupe, Blythe H Devlin, Mary Louise Markert, Thomas B Kepler

3 registry-linked trialsAbstract read
In one paragraph

Article in BMC immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00576836 phase2completednot on this map

Dose Study of Thymus Transplantation in DiGeorge Anomaly, IND 9836, #932.1

TypeinterventionalSponsorSumitomo Pharma Switzerland GmbHRan2004 to 2019Enrolled7ConditionsDiGeorge Anomaly, DiGeorge Syndrome, Complete DiGeorge Anomaly, Complete DiGeorge SyndromeArmsCultured Thymus Tissue Implantation (CTTI), Cultured Thymus Tissue Implantation with Parathyroid Transplantation
NCT01220531 nacompletednot on this map

Safety and Efficacy of Thymus Transplantation in Complete DiGeorge Anomaly, IND#9836

TypeinterventionalSponsorSumitomo Pharma Switzerland GmbHRan2010 to 2023Enrolled29ConditionsComplete DiGeorge Anomaly, DiGeorge Syndrome, DiGeorge Anomaly, Complete DiGeorge SyndromeArmsCultured Thymus Tissue
NCT02274662 phase4completednot on this mapstarted 2014, after this paper: background citation

Expanded Access Protocol Thymus Transplantation for Immunodeficiency, Hematologic Malignancies, and Autoimmune Disease Related to Poor Thymic Function

TypeinterventionalSponsorSumitomo Pharma Switzerland GmbHRan2014 to 2023Enrolled11ConditionsPoor Thymic Function, Immunodeficiency, Athymia, ImmunoreconstitutionArmsCultured Thymus Tissue, Blood Draw, Rabbit Anti-Thymocyte Globulin and Cyclosporine or Tacrolimus
3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Antigen-Specificity of T Cell Infiltrates in Biopsies With T Cell-Mediated Rejection and BK Polyomavirus Viremia: Analysis by Next Generation Sequencing.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2016
    Article
  13. Mathematics in modern immunology.Interface focus · 2016
    Review
  14. How many TCR clonotypes does a body maintain?Journal of theoretical biology · 2016
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Stanca M CiupeDepartment of Mathematics, Virginia Tech, 460 McBryde Hall, Blacksburg, VA 24060, USA. stanca@vt.edu
Blythe H Devlin
Mary Louise Markert
Thomas B Kepler

Funding

THYMIC TRANSPLANTATION IN COMPLETE DIGEORGE SYNDROMER01AI047040 · NIAID · DUKE UNIVERSITY · PI MARKERT, M. LOUISE · 1999 to 2014
$8.0M
Dynamics of TCR Repertoire Following Thymus TransplantR01AI054843 · NIAID · DUKE UNIVERSITY · PI MARKERT, M. LOUISE · 2004 to 2008
$1.9M
Dose Study of thymus TransplantationR01FD002606 · FDA · DUKE UNIVERSITY · PI MARKERT, MARY LOUISE · 2005 to 2007
$934k
FDA HHS FD-R-002606NCRR NIH HHS M03 RR60NIAID NIH HHS R01 AI 47040NIAID NIH HHS R01 AI 54843
6 · The paper itself

Abstract

backgroundT-cell receptor diversity correlates with immune competency and is of particular interest in patients undergoing immune reconstitution. Spectratyping generates data about T-cell receptor CDR3 length distribution for each BV gene but is technically complex. Flow cytometry can also be used to generate data about T-cell receptor BV gene usage, but its utility has not been compared to or tested in combination with spectratyping.

resultsUsing flow cytometry and spectratype data, we have defined a divergence metric that quantifies the deviation from normal of T-cell receptor repertoire. We have shown that the sample size is a sensitive parameter in the predicted flow divergence values, but not in the spectratype divergence values. We have derived two ways to correct for the measurement bias using mathematical and statistical approaches and have predicted a lower bound in the number of lymphocytes needed when using the divergence as a substitute for diversity.

conclusionsUsing both flow cytometry and spectratyping of T-cells, we have defined the divergence measure as an indirect measure of T-cell receptor diversity. We have shown the dependence of the divergence measure on the sample size before it can be used to make predictions regarding the diversity of the T-cell receptor repertoire.

Indexed as

CD3 ComplexCD4-Positive T-LymphocytesComplementarity Determining RegionsConfidence IntervalsFlow CytometryHumansPolymerase Chain ReactionReceptors, Antigen, T-CellSample SizeCD3 ComplexComplementarity Determining RegionsReceptors, Antigen, T-Cell

Identifiers

PMID23914737
PMCPMC3750526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.